The Diamond Broke. Color Held.

The most important thing that happened to colored stones this year did not happen in a saleroom. It happened to the diamond next door.

For a century the diamond was the hardest asset in a jewelry box: scarce, portable, and priced on that scarcity. Then the laboratory learned to grow one, chemically identical, at a fraction of the cost, and the scarcity story broke. What no one could do to a Kashmir sapphire or a Colombian emerald, someone did to the diamond. They made it reproducible. And the money that wanted a portable hard asset went looking for something a machine could not print.

It found color. This week's edition is about why, and about the one thing that could take it away.

→ Christie's confirms the rotation. In its first Luxury Trends Report, Christie's described demand for colored gemstones in 2025 as "surging," with emeralds, rubies and sapphires leading and Paraíba tourmaline drawing record-setting interest. White diamond demand, by contrast, merely stabilized as prices leveled off. When the biggest houses publish where the bidding went, this is the signal, not the noise (Christie's; Rapaport; AGTA).

→ The synthetic broke the diamond's floor. A lab-grown diamond now sells for roughly a tenth of the price of a comparable natural stone, per diamond analyst Paul Zimnisky, whose data put an unbranded one-carat lab-grown near $845 in early 2025. The pressure has reached mined prices: Rapaport's index recorded one-carat natural diamonds down 11.3 percent across 2025, and De Beers' effective rough price fell about 25 percent year over year at its first 2026 sale. A Rapaport analyst called it less a cyclical dip than a more fundamental crisis in the industry. Auction-grade colored stones cannot be manufactured to that scale, which is precisely the point (Rapaport; CNBC; TheStreet).

→ Gold set the mood. Gold touched a record above $5,100 an ounce in January before settling back above $4,500, and that surge pulled hard-asset appetite across the whole luxury category. Buyers already primed to treat gold as a hedge started treating fine colored stones the same way (CNBC).

The index tracks the 8 reference stones every week. Each row holds until a new dated transaction moves it. July is a quiet auction month, and a macro rotation does not produce a per carat print, so the index is unchanged. The story this week is the tide under all eight rows, not any single one.

Auction prices realized, not retail. Sources: Christie's, Gemfields, Bonhams, SSEF, GemGuide, Pala International.

Notable this week: every row on this table benefits from the same tailwind, and it is not gemological. It is a capital rotation out of an asset that lost its scarcity into assets that kept theirs. That is why a firming Kashmir print and a record Paraíba result and a resilient ruby clearance can all happen in the same six months. They are not eight separate stories. They are one flow of money finding eight different doors.

What the synthetic actually destroyed. A diamond's price rested on two things: scarcity and brilliance. The laboratory now delivers both, at roughly a tenth of the price, from a reactor that runs on a schedule. Scarcity produced on demand is not scarcity. The natural diamond still exists, still sells, but its story, that it is rare because the earth made few of them, is the exact story a machine now tells better and cheaper.

Why a colored stone resists the same fate. A fine colored stone is priced on things a reactor cannot reproduce at auction scale.

Christie's head of New York jewelry sales put the difference plainly this spring, describing lab-grown production as a conveyor belt and noting that "you can't do that with a sapphire or ruby or emerald." That sentence is the whole thesis. Synthetic corundum and synthetic emerald exist, and have for decades, but they do not threaten the auction market the way lab-grown diamonds threaten the natural diamond, because the value of a fine natural colored stone was never just the material. It was the specific origin, the specific saturation, and the fact that there is exactly one of it.

The rotation has a name now. The trade calls it the provenance premium, and it is why the GIA expanded its country-of-origin services at the start of 2026. As capital treats colored stones as portable wealth, origin stops being a connoisseur's footnote and becomes the pricing spine. A stone's passport is now worth as much as its face.

Which is exactly the vulnerability. Read back two weeks. The entire moat described above rests on one assumption: that a lab can reliably certify origin and treatment, and that the certificate stays true. The SSEF alerts of last month, refilled emeralds carrying honest but stale reports, and a possible new Paraíba source that blurs the Brazilian fingerprint, are attacks on that exact assumption. The diamond lost its scarcity to a reactor. Color's scarcity is real, but it is only bankable if the paperwork holds. Protect the paper and the rotation continues. Let the paper rot and color inherits the diamond's problem by another route.

1. The rotation is documented, not hoped for. This is not a dealer talking his book. It is Christie's own first Luxury Trends Report showing color surging while white diamonds only stabilized. When the primary venue publishes the flow, treat it as data. The tailwind under the index is real.

2. Tariffs are the counter-current. The same year that lifted color was, in the trade's own words, a brutal one for tariffs, raising landed costs and pushing deals out of public salerooms into private treaty. Watch for a market that looks quieter at auction while staying strong in private. Auction totals may understate demand, not reflect a top.

3. The moat is the lab report, so watch the labs, not just the stones. Color's advantage over the broken diamond is certifiable, singular origin. Everything that strengthens origin science, the GIA's expanded services, strengthens the asset. Everything that weakens it, the refill fraud, the Ethiopian Paraíba overlap, chips at the one thing holding the premium up.

→ Geneva, November. The first major post-summer test of whether the rotation Christie's documented in 2025 is accelerating or cooling. Watch the colored-stone hammer totals against the white-diamond ones in the same rooms.

→ Tariff developments. Any easing or hardening of duties on loose stones directly moves landed cost and the auction-versus-private balance. This is now a price input, not a policy footnote.

→ Origin science. GIA and SSEF follow-up on the Ethiopian tourmaline material, and any further lab alerts. The health of the report is the health of the premium.

Pro launches at 500 free subscribers. Founding rate: $99 / year, locked for life.

Reply PRO to lock the founding rate.

If you are buying a colored stone as a hedge, be honest about what the asset actually is. It is not the crystal. It is the certainty that this crystal is from where the report says, treated as the report says, and that no reactor can print another one. That certainty lives on a piece of paper from a credible lab. Buy the paper as seriously as you buy the stone, because the paper is the part the diamond just lost.

— Carat Brief

Carat Brief is editorial. Nothing here is investment, legal, or tax advice. Gemstones are illiquid and require certified verification before purchase. Work with credentialed labs: GIA, AGL, SSEF, Gübelin, Lotus Gemology.

Sources: Christie's Luxury Trends Report, via Rapaport and AGTA Prism, 2026; Rapaport Diamond Price Index; Paul Zimnisky via CNBC; De Beers via Rapaport; TheStreet; SSEF; GIA. Figures are third-party estimates and vary by source.